Eligibility for antiamyloid treatment: preparing for disease-modifying therapies for Alzheimer's disease.
Dobson R, Patterson K, Malik R, Mandal U, Asif H, Humphreys R, Payne M, O-Charoenrat E, Huzzey L, Clare A, Green K, Morton M, Sohrabi C, Singh N, Pasupathy A, Patel M, Whiteman S, Maxmin K, Bass N, Gupta B, Cooper C, Marshall C, Weil RS, Mummery CJ.
Dobson R, et al. Among authors: patel m.
J Neurol Neurosurg Psychiatry. 2024 Jun 11:jnnp-2024-333468. doi: 10.1136/jnnp-2024-333468. Online ahead of print.
J Neurol Neurosurg Psychiatry. 2024.
PMID: 38862265